Pulse Biosciences, Inc. (NASDAQ:PLSE)
| Market Cap | 3.67B+254.6% |
| Revenue (ttm) | 1.19M |
| Net Income | -80.06M-17.7% |
| EPS | -1.17-9.3% |
| Shares Out | 69.21M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,560,251 |
| Open | 50.20 |
| Previous Close | 48.79 |
| Day's Range | 48.93 - 58.62 |
| 52-Week Range | 12.56 - 58.90 |
| Beta | 1.63 |
| Analysts | Buy |
| Price Target | 45.25(-14.57%) |
| Earnings Date | Nov 4, 2026 |
About PLSE
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$PLSE stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in PLSE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PLSE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PLSE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PLSE Revenue by Segment or Geography
Source: SEC EDGAR (10-Q/10-K)
U.S. Patents
New PLSE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PLSE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in PLSE
| ETF | Est. Holding Size |
|---|---|
| IWMiShares Russell 2000 ETF | $26.24M |
| VTIVanguard Morningstar Total Stock Market ETF | $19.48M |
| IWOiShares Russell 2000 Growth ETF | $9.49M |
| VXFVanguard Extended Market ETF | $7.60M |
| SCHASchwab U.S. Small-Cap ETF | $4.40M |
| VTWOVanguard Russell 2000 ETF | $3.66M |
Estimated from each fund’s disclosed top holdings × AUM
PLSE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PLSE’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score